|
COGT | Cogent Biosciences, Inc. |
|
|
COGT | Cogent Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.08 |
| Leverage | 28.99% |
| Market Cap | $ 3.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -293.5m |
| Margin | -15342.74% |
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.